Rocky Mountain spotted fever

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 4, 2006, Pages 411-417

  Lacz, N L ^a   Schwartz, R A ^a   Kapila, R ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Rickettsiosis; RMSF; Tick borne disease; Zoonoses

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; DOXYCYCLINE;

ACUTE KIDNEY FAILURE; ANTIBIOTIC THERAPY; ARTICLE; ATAXIA; BOUTONNEUSE FEVER; CELL MIGRATION; CLINICAL FEATURE; CONGENITAL DISORDER; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; EARLY DIAGNOSIS; ENCEPHALOMYELITIS; FATALITY; FECES INCONTINENCE; FEVER; FLUORESCENT ANTIBODY TECHNIQUE; GANGRENE; HEADACHE; HISTOPATHOLOGY; HUMAN; HYPERREFLEXIA; HYPOALBUMINEMIA; HYPOTENSION; INCIDENCE; LIMB; LYME DISEASE; MENINGOENCEPHALITIS; MONARTHRITIS; NEUROIMAGING; PATHOLOGICAL ANATOMY; PATIENT EDUCATION; PRIORITY JOURNAL; PROGNOSIS; Q FEVER; RASH; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; SCRUB TYPHUS; SKIN NECROSIS; THROMBOCYTOPENIA; TICK BORNE DISEASE; TOOTH DISEASE; TRUNK; URINE INCONTINENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PATIENT EDUCATION; PROGNOSIS; ROCKY MOUNTAIN SPOTTED FEVER;

EID: 33645343325     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01489.x     Document Type: Article

References (85)

1. Walker DH, Fishbein DB. Epidemiology of rickettsial diseases. Eur J Epidemiol 1991; 7: 237-245.
2. Rudakov NV, Shpynov SN, Samoilenko IE, Tankibaev MA. Ecology and epidemiology of spotted fever group Rickettsiae and new data from their study in Russia and Kazakhstan. Ann N Y Acad Sci 2003; 990: 12-24.
3. Abrahamian FM. Consequences of delayed diagnosis of Rocky Mountain spotted fever in children -West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000. Ann Emerg Med 2001; 37: 537-540.
4. Gayle A, Ringdahl E. Tick-borne diseases. Am Fam Physician 2001; 64: 461-466.
5. Weber DJ, Walker DH. Rocky Mountain spotted fever. Infect Dis Clin North Am 1991; 5: 19-35.
6. Marshall GS, Stout GG, Jacobs RF et al. Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States. Arch Pediatr Adolesc Med 2003; 157: 443-448.
7. Treadwell TA, Holman RC, Clarke MJ, Krebs JW, Paddock CD, Childs JE. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg 2000; 63: 21-26.
8. Hilton E, DeVoti J, Benach JL et al. Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am J Med 1999; 106: 404-409.
9. Sanchez JL, Candler WH, Fishbein DB et al. A cluster of tick-borne infections: Association with military training and asymptomatic infections due to Rickettsia rickettsii. Trans R Soc Trop Med Hyg 1992; 86: 321-325.
10. Taylor JP, Tanner WB, Rawlings JA et al. Serological evidence of subclinical Rocky Mountain spotted fever infections in Texas. J Infect Dis 1985; 151: 367-369.
11. Marx RS, McCall CE, Abramson JS, Harlan JE. Rocky Mountain spotted fever. Serological evidence of previous subclinical infection in children. Am J Dis Child 1982; 136: 16-18.
12. McDade JE. Evidence supporting the hypothesis that rickettsial virulence factors determine the severity of spotted fever and typhus group infections. Ann NY Acad Sci 1991; 590: 20-26.
13. Centers for Disease Control. Rocky Mountain spotted fever - United States, 1990. MMWR Morb Mortal Wkly Rep 1991; 40: 451-453, 459.
14. Salgo MP, Telzak EE, Currie B et al. A focus of Rocky Mountain spotted fever within New York City. N Engl J Med 1988; 318: 1345-1348.
15. Henke SE, Pence DB, Demarais S, Johnson JR. Serologic survey of selected zoonotic disease agents in black-tailed jack rabbits from western Texas. J Wildl Dis 1990; 26: 107-111.
16. Dalton MJ, Clarke MJ, Holman RC et al. National surveillance for Rocky Mountain spotted fever, 1981-92: Epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995; 52: 405-413.
17. Sexton DJ, Kaye KS. Rocky Mountain spotted fever. Med Clin North Am 2002; 86: 351-360.
18. Joshi SG, Francis CW, Silverman DJ, Sahni SK. Nuclear factor κB protects against host cell apoptosis during Rickettsia rickettsii infection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity. Infect Immun 2003; 71: 4127-4136.
19. Walker DH. Rocky Mountain spotted fever: A seasonal alert. Clin Infect Dis 1995; 20: 1111-1117.
20. Elghetany MT, Walker DH. Hemostatic changes in Rocky Mountain spotted fever and Mediterranean spotted fever. Am J Clin Pathol 1999; 112: 159-168.
21. Walker DH, Crawford CG, Cain BG. Rickettsial infection of the pulmonary microcirculation: The basis for interstitial pneumonitis in Rocky Mountain spotted fever. Hum Pathol 1980; 11: 263-272.
22. Roggli VL, Keener S, Bradford WD, Pratt PC, Walker DH. Pulmonary pathology of Rocky Mountain spotted fever (RMSF) in children. Pediatr Pathol 1985; 4: 47-57.
23. Walker DH, Paletta CE, Cain BG. Pathogenesis of myocarditis in Rocky Mountain spotted fever. Arch Pathol Lab Med 1980; 104: 171-174.
24. Jackson MD, Kirkman C, Bradford WD, Walker DH. Rocky mountain spotted fever: Hepatic lesions in childhood cases. Pediatr Pathol 1986; 5: 379-388.
25. Randall MB, Walker DH. Rocky Mountain spotted fever. Gastrointestinal and pancreatic lesions and rickettsial infection. Arch Pathol Lab Med 1984; 108: 963-967.
26. Silverman DJ. Adherence of platelets to human endothelial cells infected by Rickettsia rickettsii. J Infect Dis 1986; 153: 694-700.
27. Drancourt M, Alessi MC, Levy PY, Juhan-Vague I, Raoult D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by Rickettsia conorii - and Rickettsia rickettsii -infected cultured endothelial cells. Infect Immun 1990; 58: 2459-2463.
28. Kaplanski G, Teysseire N, Farnarier C et al. IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1α-dependent pathway. J Clin Invest 1995; 96: 2839-2844.
29. Schlossberg D. Fever and rash. Infect Dis Clin North Am 1996; 10: 101-110.
30. McKinnon HD Jr, Howard T. Evaluating the febrile patient with a rash. Am Fam Physician 2000; 62: 804-816.
31. Drage LA. Life-threatening rashes: Dermatologic signs of four infectious diseases. Mayo Clin Proc 1999; 74: 68-72.
32. Thorner AR, Walker DH, Petri WA Jr. Rocky mountain spotted fever. Clin Infect Dis 1998; 27: 1353-1359.
33. Kaufmann JM, Zaenglein AL, Kaul A, Chang MW. Fever and rash in a 3-year-old girl: Rocky Mountain spotted fever. Cutis 2002; 70: 165-168.
34. Hattwick MA, O'Brien RJ, Hanson BF. Rocky Mountain spotted fever: epidemiology of an increasing problem. Ann Intern Med 1976; 84: 732-739.
35. Myers SA, Sexton DJ. Dermatologic manifestations of arthropod-borne diseases. Infect Dis Clin North Am 1994; 8: 689-712.
36. Callahan EF, Adal KA, Tomecki KJ. Cutaneous (non-HIV) infections. Dermatol Clin 2000; 18: 497-508.
37. Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 1984; 150: 480-488.
38. Kirk JL, Fine DP, Sexton DJ, Muchmore HG. Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986. Medicine (Baltimore) 1990; 69: 35-45.
39. Kirkland KB, Marcom PK, Sexton DJ, Dumler JS, Walker DH. Rocky Mountain spotted fever complicated by gangrene: Report of six cases and review. Clin Infect Dis 1993; 16: 629-634.
40. Walker DH, Gay RM, Valdes-Dapena M. The occurrence of eschars in Rocky Mountain spotted fever. J Am Acad Dermatol 1981; 4: 571-576.
41. Silber JL. Rocky Mountain spotted fever. Clin Dermatol 1996; 14: 245-258.
42. Hughes C. Rocky Mountain 'spotless' fever with an erythema migrans-like skin lesion. Clin Infect Dis 1995; 21: 1328-1329.
43. Kaplan LI. Other spotted fevers. Clin Dermatol 1996; 14: 259-267.
44. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 2001; 184: 1437-1444.
45. Paddock CD, Brenner O, Vaid C et al. Short report: Concurrent Rocky Mountain spotted fever in a dog and its owner. Am J Trop Med Hyg 2002; 66: 197-199.
46. Archibald LK, Sexton DJ. Long-term sequelae of Rocky Mountain spotted fever. Clin Infect Dis 1995; 20: 1122-1125.
47. Childs JE, Paddock CD. Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: Is there more to learn? Am J Trop Med Hyg 2002; 66: 450-457.
48. Sexton DJ, Corey GR. Rocky Mountain 'spotless' and 'almost spotless' fever: A wolf in sheep's clothing. Clin Infect Dis 1992; 15: 439-448.
49. Raoult D, Lena D, Perrimont H, Gallais H, Walker DH, Casanova P. Haemolysis with Mediterranean spotted fever and glucose-6-phosphate dehydrogenase deficiency. Trans R Soc Trop Med Hyg 1986; 80: 961-962.
50. Walker DH, Kirkman HN. Rocky Mountain spotted fever and deficiency in glucose-6-phosphate dehydrogenase. J Infect Dis 1980; 142: 771.
51. Walker DH, Hawkins HK, Hudson P. Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency. Arch Pathol Lab Med 1983; 107: 121-125.
52. Stallings SP. Rocky Mountain spotted fever and pregnancy. a case report and review of the literature. Obstet Gynecol Surv 2001; 56: 37-42.
53. Hove MG, Walker DH. Persistence of rickettsiae in the partially viable gangrenous margins of amputated extremities 5-7 weeks after onset of Rocky Mountain spotted fever. Arch Pathol Lab Med 1995; 119: 429-431.
54. Sundy JS, Allen NB, Sexton DJ. Rocky Mountain spotted fever presenting with acute monarticular arthritis. Arthritis Rheum 1996; 39: 175-176.
55. Wei TY, Baumann RJ. Acute disseminated encephalomyelitis after Rocky Mountain spotted fever. Pediatr Neurol 1999; 21: 503-505.
56. Horney LF, Walker DH. Meningoencephalitis as a major manifestation of Rocky Mountain spotted fever. South Med J 1988; 81: 915-918.
57. Conlon PJ, Procop GW, Fowler V, Eloubeidi MA, Smith SR, Sexton DJ. Predictors of prognosis and risk of acute renal failure in patients with Rocky Mountain spotted fever. Am J Med 1996; 101: 621-626.
58. Bergeron JW, Braddom RL, Kaelin DL. Persisting impairment following Rocky Mountain Spotted Fever: A case report. Arch Phys Med Rehabil 1997; 78: 1277-1280.
59. Walker DH, Burday MS, Folds JD. Laboratory diagnosis of Rocky Mountain spotted fever. South Med J 1980; 73: 1449.
60. Kaplan JE, Schonberger LB. The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg 1986; 35: 840-844.
61. Paddock CD, Holman RC, Krebs JW. Assessing the magnitude of fatal Rocky Mountain spotted fever in the United States: Comparison of two national data sources. Am J Trop Med Hyg 2002; 67: 349-354.
62. Radulovic S, Speed R, Feng HM, Taylor C, Walker DH. EIA with species-specific monoclonal antibodies: A novel seroepidemiologic tool for determination of the etiologic agent of spotted fever rickettsiosis. J Infect Dis 1993; 168: 1292-1295.
63. Procop GW, Burchette JL Jr, Howell DN, Sexton DJ. Immunoperoxidase and immunofluorescent staining of Rickettsia rickettsii in skin biopsies. A comparative study. Arch Pathol Lab Med 1997; 121: 894-899.
64. Dumler JS, Walker DH. Diagnostic tests for Rocky Mountain spotted fever and other rickettsial diseases. Dermatol Clin 1994; 12: 25-36.
65. Sexton DJ, Kanj SS, Wilson K et al. The use of a polymerase chain reaction as a diagnostic test for Rocky Mountain spotted fever. Am J Trop Med Hyg 1994; 50: 59-63.
66. Singh-Behl D, La Rosa SP, Tomecki KJ. Tick-borne infections. Dermatol Clin 2003; 21: 237-244.
67. Baganz MD, Dross PE, Reinhardt JA. Rocky Mountain spotted fever encephalitis. MR findings. AJNR Am J Neuroradiol 1995; 16: 919-922.
68. Bonawitz C, Castillo M, Mukherji SK. Comparison of CT and MR features with clinical outcome in patients with Rocky Mountain spotted fever. AJNR Am J Neuroradiol 1997; 18: 459-464.
69. Kao GF, Evancho CD, Ioffe O, Lowitt MH, Dumler JS. Cutaneous histopathology of Rocky Mountain spotted fever. J Cutan Pathol 1997; 24: 604-610.
70. Lucas S. Bacterial disease. Rocky Mountain spotted fever. Elder D et al. eds. Lever's Histopathology of the Skin, 8th edn. Lippincott-Raven, Philadelphia, 1997: 490.
71. Bradford WD, Croker BP, Tisher CC. Kidney lesions in Rocky Mountain spotted fever: A light-, immunofluorescence-, and electron-microscopic study. Am J Pathol 1979; 97: 381-392.
72. Taege AJ. Tick trouble: Overview of tick-borne diseases. Cleve Clin J Med 2000; 67 (241): 245-249.
73. Zalewska A, Schwartz RA. Boutonneusse fever. eMedicine Dermatology [Journal serial online]. 2005. Available at: http://author.emedicine.com/ derm/topic759.htm.
74. Schwartz RA, Jagar CW. Scrub typhus. eMedicine Dermatology [Journal serial online]. 2005. Available at: http://author.emedicine.com/derm/ topic841.htm.
75. Rauscher GE, Schwartz RA, Rauscher EF, Mekles TJ. Dengue fever. eMedicine Dermatology [Journal serial online]. 2005. Available at: http://author.emedicine.com/derm/topic796.htm.
76. McGinley-Smith DE, Tsao SS. Dermatoses from ticks. J Am Acad Dermatol 2003; 49: 363-392.
77. Walker DH, Henderson FW, Hutchins GM. Rocky Mountain spotted fever: mimicry of appendicitis or acute surgical abdomen? Am J Dis Child 1986; 140: 742-744.
78. Walker DH, Lesesne HR, Varma VA, Thacker WC. Rocky Mountain spotted fever mimicking acute cholecystitis. Arch Intern Med 1985; 145: 2194-2196.
79. Cale DF, McCarthy MW. Treatment of Rocky Mountain spotted fever in children. Ann Pharmacother 1997; 31: 492-494.
80. Herbert WN, Seeds JW, Koontz WL, Cefalo RC. Rocky Mountain spotted fever in pregnancy: Differential diagnosis and treatment. South Med J 1982; 75: 1063-1066.
81. Markley KC, Levine AB, Chan Y. Rocky Mountain spotted fever in pregnancy. Obstet Gynecol 1998; 91 (5 Part 2): 860.
82. Wilson ME. Prevention of tick-borne diseases. Med Clin North Am 2002; 86: 219-238.
83. Crocquet-Valdes PA, Diaz-Montero CM, Feng HM, Li H, Barrett AD, Walker DH. Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis. Vaccine 2001; 20: 979-988.
84. Steen CJ, Carbonaro PA, Schwartz RA. Arthropods in dermatology. J Am Acad Dermatol 2004; 50: 819-842.
85. Needham GR. Evaluation of five popular methods for tick removal. Pediatrics 1985; 75: 997-1002.